Fiocruz
The Latest
-
Brazil, AstraZeneca Sign $127 Million Deal To Produce Experimental COVID-19 Drug
Experimental vaccine developed by AstraZeneca shown to be effective in combating COVID-19. 
Experimental vaccine developed by AstraZeneca shown to be effective in combating COVID-19.
